DoW Vision, Clinical Trial Award
Funding Opportunity Number: HT942526VRPCTA
About the Opportunity
The fiscal year 2026 (FY26) Vision Research Program (VRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of service-connected eye injury and visual dysfunction. Research must align with at least one of the FY26 VRP Focus Areas.
Eligibility
Unrestricted (i.e., open to any type of entity above), subject to any clarification in the additional eligibility information.
Distinctive Features
- For interventions requiring Investigational New Drug (IND)/Investigational Device Exemption (IDE) or equivalent regulatory authorizations for clinical testing, the IND/IDE application or equivalent must be submitted to the relevant Regulatory Agency by the CTA application submission deadline.
- Applicants must provide documentation of communication from the Regulatory Agency indicating that the IND/IDE or equivalent is active/safe to proceed by March 1, 2027, for the application to be considered for funding.
Refer to Attachment 7: Regulatory Strategy for further details.
Review Criteria
Scored Peer Review Criteria
- Clinical Impact
- Research Strategy and Feasibility
- Recruitment, Accrual, Retention
- Regulatory Strategy and Transition Plan
- Statistical Plan and Data Analysis
- Ethical Considerations
- Personnel and Communication
Programmatic Review Criteria
- Adherence to the intent of the CTA
- Contribution to program portfolio
- Relative impact and relevance to military health
Funding Details
Estimated Total Program Funding: $2,600,000
Expected Number of Awards: 1
Assistance Listings: 12.420 -- Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Key Dates
- Posted Date: May 05, 2026
- Last Updated Date: May 05, 2026
- Original Closing Date for Applications: Nov 12, 2026
- Archive Date: Dec 12, 2026
Additional Information
Link to Additional Information
Contact Information
If you have difficulty accessing the full announcement electronically, please contact:
eBRAP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org